These results demonstrated that hepatic knockout of Af6 is sufficient to protect liver from NASH-associated injury and inflammation, and that these effects are mediated by increased levels of RIPK1 ubiquitination resulting in decreased necroptosis. The gene discussed is AFDN; the disease is metabolic dysfunction-associated steatohepatitis.